Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga October 27, 2014 at 08:21 AM EDT Sarepta Therapeutics (NASDAQ: SRPT) fell 32.51% to $15.90 in pre-market trading on the FDA requirement of additional data from Sarepta ... Read More >> Related Stocks: Gopro Inc Cl A Lakeland Inds Inc Regulus Therapeutics Sarepta Therapeutics